|
SFFLKEKGGLEGLIYSKK
|
Nef(88-105)
|
C*05 human epitope
|
SHFLKEKGGLEGLIYSQK
|
Nef(88-105)
|
human epitope
|
SfFLKEKGGLEGLIYSkK
|
Nef(88-105)
|
subtype-specific susceptible form
|
SHFLKEKGGLEGLIYSQK
|
Nef(88-105)
|
human epitope
|
SFFLKEKGGLEGLIYSKK
|
Nef(88-105)
|
human epitope
|
FFLKEKGGLEGLIHSQKR
|
Nef(89-106)
|
human epitope
|
HFLKEKGGLEGLIYSQKR
|
Nef(89-106)
|
human epitope
|
LKEKGGLEGLIYSQKRQDIL
|
Nef(91-110)
|
human epitope
|
KEKGGLEGLVYSQK
|
Nef(92-105)
|
human epitope
|
KEKGGLEGLIHSQRRQDILDL
|
Nef(92-112)
|
human epitope
|
KEKGGLEGLIHSQRRQDILDL
|
Nef(92-112)
|
human epitope
|
KEKGGLEGLIHSQRRQDILDL
|
Nef(92-112)
|
human epitope
|
EKGGLEGLIHSQRR
|
Nef(93-106)
|
A1, B8 human epitope
|
GLEGLIYSQKRQDILDLW
|
Nef(96-113)
|
human epitope
|
GLEGLIYSkKRQeILDLW
|
Nef(96-113)
|
subtype-specific susceptible form
|
LEGLIYSKKRQEILD
|
Nef(97-111)
|
human epitope
|
LEGLIYSQKRQDILD
|
Nef(97-111)
|
human epitope
|
LEGLIYSQKRQDILDLWV
|
Nef(97-114)
|
human epitope
|
LEGLIYSQKRQeILDLWV
|
Nef(97-114)
|
escape documented in this paper; observed variant
|
LIYSKKRQEILDLWV
|
Nef(100-114)
|
human epitope
|
IYSQKRQDI
|
Nef(101-109)
|
human epitope
|
IYSQKRQDILD
|
Nef(101-111)
|
human epitope
|
IhSQrRQDILD
|
Nef(101-111)
|
non-susceptible form
|
IySQRRQDILD
|
Nef(101-111)
|
observed variant
|
IYSQKRQDILDLWIY
|
Nef(101-115)
|
Cw7 human epitope
|
IYSRKRQEILDLWIY
|
Nef(101-115)
|
Cw7 human epitope
|
IHSQRRQDILDLWIY
|
Nef(101-115)
|
human epitope
|
IYSQKRQDILDLWVY
|
Nef(101-115)
|
human epitope
|
IYSKKRQEILDLWVY
|
Nef(101-115)
|
human epitope
|
IYSQKRQDILDLWVYH
|
Nef(101-116)
|
human epitope
|
vwSQKRQDILDLWVYn
|
Nef(101-116)
|
non-susceptible form; susceptible form
|
IYSQKRQDILDLWVYHTQGY
|
Nef(101-120)
|
human epitope
|
HSKRRQDIL
|
Nef(102-110)
|
human epitope
|
HSQRRQDIL
|
Nef(102-110)
|
human epitope
|
HSQKRQDIL
|
Nef(102-110)
|
human epitope
|
HSQRRQDIL
|
Nef(102-110)
|
human epitope
|
HSQRRQDILDLWIY
|
Nef(102-115)
|
B*07 human epitope
|
HSQRRQDILDLWIY
|
Nef(102-115)
|
B7 human epitope
|
HSQRRQDILDLQIYHTQGYF
|
Nef(102-121)
|
human epitope
|
SQRRQDILDLWVYHT
|
Nef(103-117)
|
Cw7 human epitope
|
SKKRQEILDLWVYHT
|
Nef(103-117)
|
human epitope
|
SKKRQkILDLWVYHT
|
Nef(103-117)
|
observed variant
|
SQRRQDILDLWIYHTQGYFPDWQNY
|
Nef(103-127)
|
B13 human epitope
|
SQRRQDILDLWIYHTQGYFPDWQNY
|
Nef(103-127)
|
B13 human epitope
|
RKRQEILDL
|
Nef(104-112)
|
B*15:03 human epitope
|
RrRQEILDL
|
Nef(104-112)
|
HLA association
|
QKRQEILDL
|
Nef(104-112)
|
B*15:03 human epitope
|
QRRQDILDL
|
Nef(104-112)
|
human epitope
|
KRRQDILDLWVY
|
Nef(104-115)
|
C*07:01 human epitope
|
KRRQDILDLWVY
|
Nef(104-115)
|
C*07:01, C*07:02 human epitope
|
KKRQEILDLWVYHTQ
|
Nef(104-118)
|
human epitope
|
KKRQEILDLWVYHTQ
|
Nef(104-118)
|
human epitope
|
KKRQEILDLWVYHTQ
|
Nef(104-118)
|
human epitope
|
KKRQEILDLWVYHTQGYF
|
Nef(104-121)
|
B*18 human epitope
|
KKRQEILDLWVYHTQGYF
|
Nef(104-121)
|
C*05, C*07, C*14 human epitope
|
QKRQDILDLWVYHTQGYF
|
Nef(104-121)
|
human epitope
|
QKRQDILDLWVYHTQGYF
|
Nef(104-121)
|
human epitope
|
kKRQeILDLWVYHTQGYF
|
Nef(104-121)
|
subtype-specific susceptible form
|
QRQDILDLW
|
Nef(105-113)
|
B*14:02 human epitope
|
KRQEILDLW
|
Nef(105-113)
|
human epitope
|
RRQDILDLWI
|
Nef(105-114)
|
A*30 human epitope
|
RRQDILDLWI
|
Nef(105-114)
|
B*13 human epitope
|
RRQDILDLWI
|
Nef(105-114)
|
B*27 human epitope
|
RgQDILDLWI
|
Nef(105-114)
|
unclear
|
ReQDILDLWI
|
Nef(105-114)
|
unclear
|
RRQDILDLWI
|
Nef(105-114)
|
B*27 human epitope
|
RRQDILDLWI
|
Nef(105-114)
|
B*27 human epitope
|
RRQDILDLWI
|
Nef(105-114)
|
B*27 human epitope
|
RRQRDILDLWI
|
Nef(105-114)
|
B*27 human epitope
|
RRQDILDLWI
|
Nef(105-114)
|
B27 human epitope
|
RRQDILDLWI
|
Nef(105-114)
|
B27 human epitope
|
RRQDILDLWI
|
Nef(105-114)
|
B*27:05 human epitope
|
RRQDILDLWI
|
Nef(105-114)
|
B*27:05 human, macaque epitope
|
RRQDILDLWI
|
Nef(105-114)
|
B*27:05 human epitope
|
RRQDILDLWI
|
Nef(105-114)
|
B*50 human epitope
|
RRQDILDLWI
|
Nef(105-114)
|
C*07 human epitope
|
RRQDILDLWI
|
Nef(105-114)
|
C*14 human epitope
|
RRQDILDLWI
|
Nef(105-114)
|
C*18 human epitope
|
RRQDILDLWI
|
Nef(105-114)
|
human epitope
|
RRQDILDLWIY
|
Nef(105-115)
|
A*29 human epitope
|
RRQDILDLWIY
|
Nef(105-115)
|
B*07 human epitope
|
KRQEILDLWVY
|
Nef(105-115)
|
B*13 human epitope
|
RRQDILDLWVY
|
Nef(105-115)
|
B*13 human epitope
|
RRQDILDLWIY
|
Nef(105-115)
|
B*13 human epitope
|
RRQDILDLWVY
|
Nef(105-115)
|
B*18 human epitope
|
KRQEILDLWVY
|
Nef(105-115)
|
B*18 human epitope
|
RRQDILDLWVY
|
Nef(105-115)
|
B*18 human epitope
|
RRQDILDLWIY
|
Nef(105-115)
|
B*18 human epitope
|
RRQDILDLWVY
|
Nef(105-115)
|
B*18 human epitope
|
KRQEILDLWVY
|
Nef(105-115)
|
B18, C*07:01 human epitope
|
RRQDILDLWVY
|
Nef(105-115)
|
B*18:01 human epitope
|
RRQDILDLWVY
|
Nef(105-115)
|
B*18:01 human epitope
|
KRQEILDLWVY
|
Nef(105-115)
|
B*18:01, B*44:03 human epitope
|
RRQDILDLWVY
|
Nef(105-115)
|
B*18:01, C*07:01, C*07:02 human epitope
|
RRQDILDLWIY
|
Nef(105-115)
|
B*27 human epitope
|
KRQEILDLWVY
|
Nef(105-115)
|
B*27 human epitope
|
RRQDILDLWVY
|
Nef(105-115)
|
B*27 human epitope
|
RRQDILDLWIY
|
Nef(105-115)
|
B*35:02, B*35:03, B*53:01 human epitope
|
RRQDILDLWVY
|
Nef(105-115)
|
B*44 human epitope
|
KRQEILDLWVY
|
Nef(105-115)
|
B*44 human epitope
|
KRQEILDLWVY
|
Nef(105-115)
|
B*57 human epitope
|
KRQEILDLWVY
|
Nef(105-115)
|
B*58:01 human epitope
|
KRQEILDLWVY
|
Nef(105-115)
|
C*07 human epitope
|
RRQDILDLWVY
|
Nef(105-115)
|
C*07 human epitope
|
RRQDILDLWVY
|
Nef(105-115)
|
C*07 human epitope
|
RRQDILDLWVY
|
Nef(105-115)
|
C*07 human epitope
|
KRQEILDLWVY
|
Nef(105-115)
|
C*07 human epitope
|
RRQDILDLWIY
|
Nef(105-115)
|
C*07 human epitope
|
KRQEILDLWVY
|
Nef(105-115)
|
C*07 human epitope
|
RRQDILDLWIY
|
Nef(105-115)
|
C*07 human epitope
|
KRQDILDLWVY
|
Nef(105-115)
|
C*07:01 human epitope
|
rRQDILDLWVY
|
Nef(105-115)
|
diminished response
|
KRQeILDLWVY
|
Nef(105-115)
|
diminished response
|
KRQEILDLWVY
|
Nef(105-115)
|
C*07:01 human epitope
|
KRQEILDLWVY
|
Nef(105-115)
|
C*07:01 human epitope
|
qRQdILDLWVY
|
Nef(105-115)
|
diminished response; escape documented in this paper; non-susceptible form; susceptible form
|
KRQdILDLWVY
|
Nef(105-115)
|
non-susceptible form
|
KRQDILDLWVY
|
Nef(105-115)
|
C*07:01 human epitope
|
KRQEILDLWVY
|
Nef(105-115)
|
C*07:01 human epitope
|
KRQDILDLWIY
|
Nef(105-115)
|
C*07:01 human epitope
|
KRQEILDLWVY
|
Nef(105-115)
|
C*07:01, C*07:02 human epitope
|
KRQEILDWVY
|
Nef(105-115)
|
C*07:02 human epitope
|
KRQEILDLWVY
|
Nef(105-115)
|
C*07:02 human epitope
|
KRQDILDWVY
|
Nef(105-115)
|
C*07:02 human epitope
|
KRQeILDWVY
|
Nef(105-115)
|
susceptible form
|
KRQEILDLWVY
|
Nef(105-115)
|
C*07:02 human epitope
|
KRQEILDLWVY
|
Nef(105-115)
|
C*07:02 human epitope
|
RRQDILDLWIY
|
Nef(105-115)
|
Cw7 human epitope
|
RRQDILDLWIY
|
Nef(105-115)
|
Cw7 human epitope
|
KKQEILDLWVY
|
Nef(105-115)
|
Cw7 human epitope
|
KRQEILDLWVY
|
Nef(105-115)
|
Cw7 human epitope
|
KRQEILDLWVY
|
Nef(105-115)
|
Cw7 human epitope
|
KRQDILDLWVY
|
Nef(105-115)
|
Cw7 human epitope
|
KRQDILDLWVY
|
Nef(105-115)
|
Cw7 human epitope
|
KRQDILDLWVY
|
Nef(105-115)
|
Cw7 human epitope
|
rRQDILDLWVY
|
Nef(105-115)
|
susceptible form
|
KRQeILDLWVY
|
Nef(105-115)
|
susceptible form
|
rRQeILDLWVY
|
Nef(105-115)
|
susceptible form
|
KRQDILDLWiY
|
Nef(105-115)
|
susceptible form
|
RRQDILDLWIY
|
Nef(105-115)
|
Cw7 human epitope
|
KRQDILDLWVY
|
Nef(105-115)
|
human epitope
|
RRQDILDLWIY
|
Nef(105-115)
|
human epitope
|
KRREILDLWVY
|
Nef(105-115)
|
human epitope
|
RRQDILDLWIY
|
Nef(105-115)
|
human epitope
|
kRQDILDLWvY
|
Nef(105-115)
|
observed variant; susceptible form
|
KRQDILDLWVY
|
Nef(105-115)
|
human epitope
|
KRQeILDLWVY
|
Nef(105-115)
|
HLA association; susceptible form
|
RRQEILDLWIY
|
Nef(105-115)
|
human epitope
|
KRQDILDLWVYHTQG
|
Nef(105-119)
|
B57 human epitope
|
RRQDILDLWVYHTQG
|
Nef(105-119)
|
B57 human epitope
|
KRQDILDLWVYHTQG
|
Nef(105-119)
|
human epitope
|
RRQDILDLWIYHTQG
|
Nef(105-119)
|
human epitope
|
KRQEILDLWVYHTQGYF
|
Nef(105-121)
|
human epitope
|
KRQDILDLWVYHTQGYFP
|
Nef(105-122)
|
human epitope
|
RQDILDLWV
|
Nef(106-114)
|
B*13 human epitope
|
RQDILDLWI
|
Nef(106-114)
|
B*13 epitope
|
RQDILDLWI
|
Nef(106-114)
|
B*13 human epitope
|
RQDILDLWI
|
Nef(106-114)
|
B*13 human epitope
|
RQDILDLWV
|
Nef(106-114)
|
B*13 human epitope
|
RQDILDLWI
|
Nef(106-114)
|
B13 human epitope
|
RQDILDLWv
|
Nef(106-114)
|
susceptible form
|
RkDILDLWI
|
Nef(106-114)
|
diminished response
|
RQeILDLWI
|
Nef(106-114)
|
diminished response
|
aQDILDLWI
|
Nef(106-114)
|
diminished response
|
RQaILDLWI
|
Nef(106-114)
|
diminished response
|
RrDILDLWv
|
Nef(106-114)
|
diminished response
|
RQDILDLWI
|
Nef(106-114)
|
B*13:02 human epitope
|
RrDILDLWI
|
Nef(106-114)
|
HLA association; diminished response; escape documented in this paper
|
RQDILDLWV
|
Nef(106-114)
|
B*13:02 human epitope
|
RQDILDLWV
|
Nef(106-114)
|
B*13:02 human epitope
|
RQDILDLWI
|
Nef(106-114)
|
B*15:24 human epitope
|
RQDILDLWI
|
Nef(106-114)
|
B*57 human epitope
|
RQDILDLWI
|
Nef(106-114)
|
C*01 human epitope
|
RQDILDLWI
|
Nef(106-114)
|
C*15 human epitope
|
RQDILDLWI
|
Nef(106-114)
|
human epitope
|
RQDILDLWV
|
Nef(106-114)
|
human epitope
|
RQDILDLWi
|
Nef(106-114)
|
observed variant
|
RQDILDLWIY
|
Nef(106-115)
|
A*29 human epitope
|
RQDILDLWIY
|
Nef(106-115)
|
B*07 human epitope
|
RQDILDLWIY
|
Nef(106-115)
|
B*13 human epitope
|
RQDILDLWIY
|
Nef(106-115)
|
B*15:02 human epitope
|
RQDILDLWIY
|
Nef(106-115)
|
B*18 human epitope
|
RQDILDLWIY
|
Nef(106-115)
|
B*27 human epitope
|
RQDILDLWIY
|
Nef(106-115)
|
B7 human epitope
|
RQDILDLWVY
|
Nef(106-115)
|
B7, Cw7 human epitope
|
RQDILDLWIY
|
Nef(106-115)
|
C*07 human epitope
|
RQDILDLWVY
|
Nef(106-115)
|
C*07 human epitope
|
RQDILDLWVY
|
Nef(106-115)
|
C*07:02 human epitope
|
RQDILDLWiY
|
Nef(106-115)
|
altered HLA expression
|
RQDILDLWVY
|
Nef(106-115)
|
Cw7 human epitope
|
RQDILDLWIY
|
Nef(106-115)
|
human epitope
|
RQDILDLWVY
|
Nef(106-115)
|
human epitope
|
RQDILDLWiY
|
Nef(106-115)
|
observed variant
|
RQDILDLWVYH
|
Nef(106-116)
|
human epitope
|
RQDILDLWiYH
|
Nef(106-116)
|
non-susceptible form; observed variant
|
RQEILDLWVYHTQGY
|
Nef(106-120)
|
Cw7 human epitope
|
QDILDLWIY
|
Nef(107-115)
|
B*18 human epitope
|
QEILDLWVY
|
Nef(107-115)
|
B*18:01, B*44:02, B44 supertype human epitope
|
QEILDLWVY
|
Nef(107-115)
|
B*44 human epitope
|
QEILDLWVY
|
Nef(107-115)
|
B44 human epitope
|
QEILDLWVY
|
Nef(107-115)
|
B*44:02, B*44:03 human epitope
|
QEILDLWVY
|
Nef(107-115)
|
B*44:03 human epitope
|
QEILDLWVY
|
Nef(107-115)
|
human epitope
|
REILDLWVY
|
Nef(107-115)
|
human epitope
|
QEILDLWVY
|
Nef(107-115)
|
human epitope
|
QdILDLWVY
|
Nef(107-115)
|
susceptible form
|
QEILDLWiY
|
Nef(107-115)
|
susceptible form
|
QEILDaWVY
|
Nef(107-115)
|
susceptible form
|
QEIaDLWVY
|
Nef(107-115)
|
susceptible form
|
QEILDLWVh
|
Nef(107-115)
|
non-susceptible form
|
QEILaLWVY
|
Nef(107-115)
|
non-susceptible form
|
QDILDLWIY
|
Nef(107-115)
|
human epitope
|
DILDLWVYHTQ
|
Nef(107-117)
|
human epitope
|
DILDLWiYHTQ
|
Nef(107-117)
|
non-susceptible form; observed variant
|
QDILDLWIYHT
|
Nef(107-117)
|
human epitope
|
QDILDLWvYHT
|
Nef(107-117)
|
non-susceptible form; observed variant
|
DILDLWIY
|
Nef(108-115)
|
C*07:01 human epitope
|
DILDLWIY
|
Nef(108-115)
|
Cw7 human epitope
|
DILDLWVH
|
Nef(108-115)
|
human epitope
|
EILDLWVYH
|
Nef(108-116)
|
human epitope
|
EILDLWVYHTQGYFP
|
Nef(108-122)
|
human epitope
|
ILDLWVYHT
|
Nef(109-117)
|
A*02:01 human epitope
|
ILDLWVYHT
|
Nef(109-117)
|
A2 human epitope
|
ILDLWIYHT
|
Nef(109-117)
|
human epitope
|
ILDLWVYHTQG
|
Nef(109-119)
|
human epitope
|
ILDLWiYHTQG
|
Nef(109-119)
|
non-susceptible form; observed variant
|
ILDLWVYHTQGYFPD
|
Nef(109-123)
|
B57 human epitope
|
DLWVYHTQGYFPDWQNYTPG
|
Nef(111-130)
|
human epitope
|
LWVYHTQGYFPDWQN
|
Nef(112-126)
|
human epitope
|
LWVYHTQGYFPDWQN
|
Nef(112-126)
|
human epitope
|
LWVYHTQGYFPDWQN
|
Nef(112-126)
|
human epitope
|
LWVYHTQGYFPDWQN
|
Nef(112-126)
|
human epitope
|
LWVYHTQGYFPDWQNY
|
Nef(112-127)
|
human epitope
|
LWIYHTQGYFPDWQNYTPGPGV
|
Nef(112-133)
|
human epitope
|
LWIYHTQGYFPDWQNYTPGPGV
|
Nef(112-133)
|
human epitope
|
LWIYHTQGYFPDWQNYTPGPGV
|
Nef(112-133)
|
human epitope
|
WIYHTQGYF
|
Nef(113-121)
|
A*01 human epitope
|
WIYHTQGYF
|
Nef(113-121)
|
human epitope
|
WVYHTQGYFPDWQNY
|
Nef(113-127)
|
B57 human epitope
|
WIYHTQGYFDPWQNY
|
Nef(113-127)
|
human epitope
|
WIYnTQGYFDPWQNY
|
Nef(113-127)
|
observed variant
|
WVYHTQGYFPDWQNY
|
Nef(113-127)
|
human epitope
|
WIYHTQGYFPDWQNYT
|
Nef(113-128)
|
A*01 human epitope
|
WIYHTQGYFPDWQNYT
|
Nef(113-128)
|
A1 human epitope
|
WIYHTQGYFPDWQNYT
|
Nef(113-128)
|
B17 human epitope
|
WIYHTQGYFPDWQNYT
|
Nef(113-128)
|
B*37 human epitope
|
WVHHTQGYFPDWQNYT
|
Nef(113-128)
|
human epitope
|
VYHTQGYFPDWQNY
|
Nef(114-127)
|
human epitope
|
YHTQGYFPDW
|
Nef(115-124)
|
B17 human epitope
|
YHTQGYFPDWQ
|
Nef(115-125)
|
B17 human epitope
|
YHTQGYFPDWQNYTP
|
Nef(115-129)
|
human epitope
|